Proteomics and metabolomics delve into the dynamic functional layers of biological systems, offering critical insights beyond genomic information. Proteomics focuses on large-scale analysis of protein expression, structure, interactions, and post-translational modifications, shedding light on cellular behavior and disease mechanisms. Metabolomics, on the other hand, profiles the complete set of small-molecule metabolites within a biological system, providing a snapshot of physiological states and metabolic changes in real time. These disciplines are instrumental in biomarker discovery, drug development, systems biology, and personalized medicine. Advanced tools such as mass spectrometry, NMR spectroscopy, and bioinformatics platforms are essential in navigating the complexity of biological networks. Proteomics and metabolomics collectively contribute to understanding disease progression, optimizing therapeutics, and predicting treatment outcomes with unparalleled precision.
Title : Renewed novel biotech ideas, with bioreactor bioengineering economic impact
Murray Moo Young, University of Waterloo, Canada
Title : Osmotic lysis–driven Extracellular Vesicle (EV) engineering
Limongi Tania, University of Turin, Italy
Title : Bioherbicides for eco-friendly weed management: From fields to commercialization, constraints and solutions for sustainable agriculture
K R Aneja, Kurukshetra University, India
Title : Predicting wound closure and future segmentation masks in wound healing assays
Alfredo De Cillis, Univeristy of Salento, CNR Nanotec, Italy
Title : Utilizing complex coacervation to promote the controlled crystallization of hydrophobic drugs
Anvesha Subramanian, University of Houston, United States
Title : Improving health in over 40,000 patients: The impact of nanomedicine fighting antibiotic resistant infections
Thomas J Webster, Brown University, United States